Psychiatric Disorders During Pregnancy - MGH Center for Women's Mental Health

The Importance of Proper Dosing of Antidepressants during Pregnancy

Pregnancy and the postpartum period is a time of increased risk for depression. Therefore, women who are treated with antidepressant medications must consider whether or not to stay on medication during pregnancy. Despite reassuring data regarding the reproductive safety of various antidepressants, a woman may prefer not to continue medication during pregnancy due to concerns about long term effects of medication on the baby. However, by discontinuing antidepressant medication, a woman increases her risk of depression during pregnancy. This is a highly personal decision for women as the potential risks of continuing medication must be weighed against the possibility of relapse and the potential effects of untreated depression on the pregnancy and baby.

By MGH Center for Women's Mental Health|2015-08-12T16:58:36-04:00August 30th, 2010|Anxiety Disorders, Depressive Disorders, Medication, Pregnancy & Medications, Psychiatric Disorders During Pregnancy, Treatment|Comments Off

Non-Pharmacologic Options for the Treatment of Antenatal Depression: A Quick Review

About 15% of women suffer from depression during pregnancy, and the rate of depressive illness is greater in women with pre-existing histories of depression. While there are data to support the use of certain antidepressants during pregnancy, many women are reluctant to seek pharmacologic treatment during pregnancy and may benefit from efficacious non-pharmacologic options. In a recent review article from Medscape, Christopher Tjoa and colleagues from the University of Pennsylvania summarize the literature assessing the efficacy of non-pharmacologic options for the treatment of antenatal depression.

By MGH Center for Women's Mental Health|2015-08-12T16:51:45-04:00July 27th, 2010|Depressive Disorders, Psychiatric Disorders During Pregnancy, Psychotherapy, Treatment|Comments Off

Anxiety During Pregnancy Predicts Worse Outcomes

In treating pregnant women with mood or anxiety disorders, we tend to focus primarily on the reproductive safety of psychotropic medications; however, it must be recognized that withholding or withdrawing pharmacologic treatment for depression or anxiety during pregnancy may carry some degree of risk. Untreated psychiatric illness in the mother cannot be considered a benign event, and a number of studies have indicated that depression during pregnancy may negatively affect pregnancy outcomes (reviewed in Bonari 2004).

By Ruta Nonacs, MD PhD|2024-03-24T11:56:41-04:00July 14th, 2010|Anxiety Disorders, Outcomes, Pregnancy Outcomes, Psychiatric Disorders During Pregnancy|Comments Off

MOTHERS Act Becomes Law

As part of the landmark health insurance reform bill that passed Congress on Monday, the Melanie Blocker Stokes MOTHERS Act – legislation sponsored by U.S. Senator Robert Menendez (D-NJ) – will become law. The legislation will establish a comprehensive federal commitment to combating postpartum depression through new research, education initiatives and voluntarily support service programs. The legislation is designed to:

By MGH Center for Women's Mental Health|2015-08-12T16:28:04-04:00March 29th, 2010|Advocacy, Postpartum Psychiatric Disorders, Psychiatric Disorders During Pregnancy|Comments Off

Acupuncture for the Treatment of Depression During Pregnancy

Depression during pregnancy is relatively common, affecting about 10 to 15% of women. While there is a growing body of literature supporting the reproductive safety of certain antidepressants, many women and their physicians would prefer to avoid the use of these medications during pregnancy; thus, there is a clear need for effective non-pharmacologic treatments for women who suffer from depression during pregnancy.

By MGH Center for Women's Mental Health|2015-08-12T16:16:02-04:00February 23rd, 2010|Alternative & Complementary, Depressive Disorders, Psychiatric Disorders During Pregnancy, Treatment|Comments Off

Panic Disorder Increases the Risk of Adverse Birth Outcomes

Anxiety often results in the activation of the sympathetic nervous system. This activation is commonly known as the “fight or flight response”; symptoms may include increased heart rate, shortness of breath, perspiration, chest pain, and nausea or diarrhea. Activation of the fight or flight response is also associated with the activation of numerous other responses in the body, including the production of various stress hormones, including cortisol.

By MGH Center for Women's Mental Health|2015-08-12T15:26:31-04:00December 8th, 2009|Anxiety Disorders, Outcomes, Pregnancy Outcomes, Psychiatric Disorders During Pregnancy|Comments Off

New Research: Treatment Decisions by Pregnant Women with Bipolar Disorder

Choosing whether to maintain or discontinue mood stabilizer treatment during pregnancy requires weighing the risks of teratogenic outcomes associated with exposure to a particular drug against the risks of recurrence of untreated affective illness. However, [...]

By MGH Center for Women's Mental Health|2016-03-28T13:23:58-04:00September 19th, 2009|Bipolar Disorder, Psychiatric Disorders During Pregnancy, Treatment|Comments Off

Prepregnancy Depressive Mood is a Risk Factor for Preterm Birth

There have been multiple studies suggesting that depression during pregnancy increases the risk for preterm labor. Most studies do not attribute this increase in risk to antidepressant exposure, but to the effects of the depression itself. The mechanism is believed to be related to increased levels of corticotropin releasing hormone (CRH) which is triggered by stress. Elevated levels of CRH have been shown to be a predictor of preterm birth.

By MGH Center for Women's Mental Health|2015-08-12T14:53:20-04:00July 28th, 2009|Depressive Disorders, Outcomes, Pregnancy Outcomes, Psychiatric Disorders During Pregnancy|Comments Off

OCD in Pregnant and Postpartum Women

The lifetime prevalence rate of obsessive-compulsive disorder (OCD) has been consistently estimated to be 2%-3% in the general adult population throughout the world, making OCD one of more common psychiatric diagnoses; however research on OCD in pregnancy and peurperium has been limited.

By MGH Center for Women's Mental Health|2015-08-12T14:45:14-04:00June 18th, 2009|Anxiety Disorders, Postpartum Psychiatric Disorders, Prevalence & Risk Factors, Psychiatric Disorders During Pregnancy|Comments Off

Maternal Depression During Pregnancy May Lead to Infant Sleep Problems

About 15% of women suffer from depression during pregnancy, and many reports have suggested that depression during pregnancy may have negative effects on the fetus. A new study from researchers at the University of Michigan indicates a link between depression during pregnancy and infant sleep problems.

By MGH Center for Women's Mental Health|2015-08-12T14:34:16-04:00May 12th, 2009|Child Outcomes, Depressive Disorders, Outcomes, Postpartum Psychiatric Disorders, Psychiatric Disorders During Pregnancy|Comments Off